ACE Pharmaceuticals Belgium SRL
1.0 FTEACE Pharmaceuticals Belgium reported total assets of €1.59m at the end of the 2025 financial year (annual accounts filed with the NBB on 09 Jul 2026), with 1 full-time equivalent.
By total assets for 2025, ACE Pharmaceuticals Belgium ranks in the top half of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of ACE Pharmaceuticals Belgium shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +233 % Total assets +763 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ACE Pharmaceuticals Belgium's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 231,722 € | ||||
| Equity | 410,226 € | ||||
| Cash | 544,276 € | ||||
| EBITDA | 408,481 € | ||||
| Total assets | €1.59m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jul 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
ACE Pharmaceuticals Belgium's financial analysis
- Solvency25.8%sector median: 45.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ACE Pharmaceuticals Belgium
7 active director(s) in the register.
and 1 more
ACE Pharmaceuticals Belgium's shareholders and holdings →ACE Pharmaceuticals Belgium's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0732.788.379
- VAT number
- BE0732788379
- Peppol
- Registered · 0208:0732788379 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Aug 2019
- Registered office
- 9831 Sint-Martens-Latem
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 09 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
ACE Pharmaceuticals Belgium (SRL) has been based in Sint-Martens-Latem since 2019, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 231,722 € and equity of 410,226 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 25.8%, below the median of its sector (45.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to ACE Pharmaceuticals Belgium
Companies in the same business, of comparable size and area, outside its group.
- Sakura Finetek Belgium Manufacture of medical and dental instruments and supplies Antwerp · balance sheet €1.89m
- JCM Dental Wholesale of pharmaceutical and medical goods Braine-l'Alleud · balance sheet 276,276 €
- Honeypatch Manufacture of pharmaceutical preparations Liège · balance sheet 330,409 €
- Bedal International Wholesale of pharmaceutical and medical goods Diepenbeek · balance sheet €4.50m
- Bucci Industries Benelux Wholesale of pharmaceutical and medical goods Jemeppe-sur-Sambre · balance sheet €1.14m
- Closson Wholesale of pharmaceutical and medical goods Wellin · balance sheet €1.60m
- Eureka Pharma Wholesale of pharmaceutical and medical goods Kuurne · balance sheet €1.90m
- ICU Medical Belgium Wholesale of pharmaceutical and medical goods Leuven · balance sheet €1.91m
Frequently asked questions about ACE Pharmaceuticals Belgium
What is the revenue of ACE Pharmaceuticals Belgium?
ACE Pharmaceuticals Belgium files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ACE Pharmaceuticals Belgium?
In Belgium, the VAT number is the company number prefixed with BE: BE0732788379 for ACE Pharmaceuticals Belgium, if the company is VAT-registered. Its company number (CBE) is 0732.788.379.
Where is the registered office of ACE Pharmaceuticals Belgium?
According to the CBE register, the registered office of ACE Pharmaceuticals Belgium is in 9831 Sint-Martens-Latem.
What is the equity of ACE Pharmaceuticals Belgium?
At the close of the 2025 financial year, the equity of ACE Pharmaceuticals Belgium amounts to 410,226 €, a solvency of 25.8% of total assets.
How many people work at ACE Pharmaceuticals Belgium?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages ACE Pharmaceuticals Belgium?
The register lists 7 active mandates at ACE Pharmaceuticals Belgium. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is ACE Pharmaceuticals Belgium within its sector?
By total assets for 2025, ACE Pharmaceuticals Belgium ranks in the top half of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year.
The full file of ACE Pharmaceuticals Belgium
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →